Seminar highlights | San Diego
When
April 29, 2025
2:30 p.m. - Registration
3:00 p.m. - Panel Discussion
5:00 p.m. - Networking with refreshments
Where
The Faculty Club at UCSD
9500 Gilman Drive MC 0121, 3035 Muir Ln
La Jolla, CA 92093
Fee: No Cost.
Limited Seats.
Register below.
Panel Discussion
Topics of the panel include: Advancing Research in Genomic Medicine, RNA Production and Manufacturing Challenges, the role of AI in Research and Operations
Featuring:
Gene Yeo, PhD
UCSD Dept of Cellular and Molecular Medicine
Dr. Gene Yeo is a Professor of Cellular and Molecular Medicine at the University of California, San Diego (UCSD), specializing in RNA biology and post-transcriptional gene regulation. He holds dual degrees from the University of Illinois, Urbana-Champaign, a Ph.D. in Computational Neuroscience from MIT, and an MBA from UCSD. Dr. Yeo's research focuses on RNA-binding proteins and their roles in gene expression, contributing significantly to understanding diseases like neurodegeneration and cancer. He is Director of the Center for RNA technologies and therapeutics at UCSD and Scientific Director of the Sanford Consortium for Regenerative Medicine. He is also Chief Scientist of Sanford Laboratories for Innovative Medicines.
Featuring:
Andy Geall, PhD
Chief Development Officer & Co-Founder, Replicate BioScience
Dr. Andrew Geall is a biotechnology leader and the Chief Development Officer and co-founder of Replicate Bioscience, leading innovations in self-replicating RNA therapies. He previously held senior roles at Precision NanoSystems, Avidity Biosciences, and Novartis, contributing to major advancements in mRNA and RNA delivery. He played a key role in raising over $100 million in funding and taking Avidity public. Dr. Geall holds a Ph.D. in non-viral gene delivery from the University of Bath and is an inventor on over 200 issued patents.
Featuring:
Padma Kodukula, PhD
Life Sciences Executive
Padma Kodukula is a life sciences executive with over 25 years of expertise spanning genomics, cell and gene therapy and protein engineering for therapeutic innovation. A scientist-turned-business leader, Padma has driven platform building, therapeutic pipeline development, business development strategy, and deal-making to create significant value in the biotech sector. Her notable leadership roles include serving as Chief Business Officer at Precision NanoSystems and A-Alpha Bio, where she was instrumental in creating substantial company value and successful exits, including Precision NanoSystems' acquisition by Danaher Corporation and securing pharma partnerships for A-Alpha Bio.
Featured Presentation
Journey through the world of RNA vaccines and therapeutics | Explore saRNA, CRISPR, and modified nucleotides
Kate Broderick, PhD
Chief Innovation Officer, Maravai LifeSciences
Dr. Kate Broderick is the Chief Innovation Officer at Maravai LifeSciences, leading scientific innovation in nucleic acid technologies. Previously, she spent 15 years at Inovio Pharmaceuticals, spearheading vaccine development for diseases like Ebola, Zika, and COVID-19. She holds a Ph.D. from the University of Glasgow and conducted postdoctoral research at UC San Diego.
Questions?
Email us at marketing@trilinkbiotech.com
TriLink BioTechnologies does not sell or distribute your information to third parties. For more information, please refer to our Privacy Policy
